Showing 61-70 of 3844 results for "".
ASDS Quest Keeps Members In the Know
https://practicaldermatology.com/topics/practice-management/asds-quest-keeps-members-in-the-know/18320/Quest is the American Society for Dermatologic Surgery's digital knowledge network, and it allows members to discuss difficult cases, share tips and interact with one another. Dr. Cox discusses all of the perks of Quest with host Joel Cohen, MD.FDA Approves New Melanoma Treatment with Novel MOA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dwtv-9-11-14--iloojede/19075/Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalled.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Diagnostic Approach for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, describes his diagnostic algorithm for prurigo nodularis.Treatments for Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/treatments-for-prurigo-nodularis/37156/Alina Bridges, DO, Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, provides an overview of therapeutic options for the treatment of prurigo nodularis.Noah Worcester 2024: Dr. Green and Dr. Weinstein on Medicare
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-green-and-dr-weinstein-medicare/24582/Noah Worcester 2024: Dr. Green and Dr. Weinstein on MedicarePsoriasis Pipeline Update: JNJ-2113, A Novel Oral IL-23 Receptor Antagonist Peptide, Shows Promise in a Phase 2b Study
https://practicaldermatology.com/topics/psoriasis/psoriasis-pipeline-update-jnj-2113-a-novel-oral-il-23-receptor-antagonist-peptide-shows-promise-in-a-phase-2b-study/20207/Laura Korb Ferris, MD, PhD, discusses the topline results from a Phase 2b trial of JNJ-2113, a novel oral IL-23 receptor antagonist peptide that’s being developed for moderate-to-severe plaque psoriasis.FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.Non-Biologics in Treatment and Management of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/non-biologics-in-treatment-and-management-of-prurigo-nodularis/48785/James Q. Del Rosso, DO, FAOCD, discusses the utility of topical therapies, cleansers, moisturizers, and phototherapy in treatment and management of prurigo nodularis.